title: The efficacy of radiotherapy as postoperative treatment for desmoid tumors.
abstract: OBJECTIVE
  The purpose of this study was to determine if radiotherapy is a beneficial adjuvant treatment after desmoid tumor resection.
  
  
  METHODS
  A retrospective analysis was performed on 54 patients who underwent surgery without prior radiation at our institution between 1982 and 1998 to remove a desmoid tumor. Thirty-five patients had adjuvant radiation therapy after surgery, and 19 patients had surgery alone without immediate postoperative radiation. Sixteen of the 35 patients who underwent immediate postoperative radiation treatment had at least one prior resection before reoperation at our institution. Recurrence was defined as radiographic increase in tumor size after treatment. Follow-up interval (mean 39 months) and duration of local control were measured from the date of surgery at our institution. Potential prognostic factors for time to tumor progression were analyzed.
  
  
  RESULTS
  Adjuvant treatment with radiation was the only significant prognostic factor for local control. The five-year actuarial local control rate was 81% for the 35 patients who underwent radiation in addition to surgery, compared to 53% for the 19 patients who underwent surgery alone (p = 0.018). For the patients who did not receive adjuvant radiation, only younger age at the time of surgery was associated with increased risk of failure (p = 0.035). Gross or microscopic margin status and number of prior operations were not detected as prognostic for local failure. For patients who did receive postoperative radiation, only abdominal location was associated with increased risk of failure (p = 0.0097).
  
  
  CONCLUSIONS
  Radiation treatment as an adjuvant to surgery improved local control over surgery alone. Multiple operations before adjuvant radiation did not decrease the probability of subsequent tumor control. Radiation should be considered as adjuvant therapy to surgery if repeated surgery for a recurrent tumor would be complicated by a significant risk of morbidity.
authors.affiliation: University of Washington School of Medicine, Seattle, WA, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Jelinek
authors.forename: K J
authors.initials: KJ
authors.lastname: Stelzer
authors.forename: E
authors.initials: E
authors.lastname: Conrad
authors.forename: J
authors.initials: J
authors.lastname: Bruckner
authors.forename: M
authors.initials: M
authors.lastname: Kliot
authors.forename: W
authors.initials: W
authors.lastname: Koh
authors.forename: G E
authors.initials: GE
authors.lastname: Laramore
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D005260:Female; D018221:Fibromatosis, Abdominal / Q000532:radiotherapy* / Q000601:surgery*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D011878:Radiotherapy / Q000009:adverse effects; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies